James has been named vice president of sales and marketing for Response Genetics, Inc., a company focused on the development and commercialization of molecular diagnostic tests for cancer. In this newly created position, he will be responsible for leading the company’s ResponseDX strategic and operational sales and marketing activities including the expansion of the company’s direct sales efforts and identifying new service offerings.
James joins Response Genetics from Clarient, Inc. where he started in 2004 when the company was known as Chromavision Medical Systems. He recruited and developed the original Clarient sales team and worked with the marketing group to prioritize product development. During his tenure, he directly helped the sales team grow to an approximately $115 million revenue generating organization at the time of its acquisition by GE Healthcare.
James has spent the last 20 plus years in cancer diagnostics. He spent the first six years in pharmaceutical sales moving into leadership roles. He joined Impath in 1995 as a Territory Sales Manager before being promoted to director of sales for the western region.
Under his leadership revenue grew exponentially. After nine successful years, James was recruited to UCLA Medical Center as the director of sales for UCLA’s pathology outreach program.